Fluifort Syrup 200 ml 9% Carbocysteine With Measuring Cup

WARNINGS
Mucolytics can induce bronchial obstruction in children younger 'less than 2 years. In fact, the drainage capacity of the bronchial mucus is limited in this age group, due to the physiological characteristics of the respiratory tract. They should therefore not be used in children younger 'less than 2 years. There are no known phenomena of addiction or dependence. Patients with rare hereditary problems of glucose intolerance, glucose-galactose malabsorption or sucrose-isomaltase enzyme insufficiency should not take this medicine. The product contains methyl para-hydroxybenzoate, known for the possibility of causing urticaria. In general, para-hydroxybenzoates can cause delayed reactions, such as contact dermatitis and rarely immediate reactions with manifestation of urticaria and bronchospasm. The syrup does not contain gluten; therefore it can be administered to patients with celiac disease. It does not contain aspartame; therefore it can be administered to patients with phenylketonuria.
PHARMACOTHERAPEUTIC CATEGORY
Prepare for coughs and colds.
STORAGE
Do not store above 25 degrees C.
CONTRAINDICATIONS / SECONDARY EFFECT
Hypersensitivity 'to the active substance or to any of the excipients. Gastroduodenal ulcer. Pregnancy and breastfeeding. Children under 2 years of age.
NAME
FLUIFORT 90 MG / ML SYRUP
EXCIPIENTS
Sucrose, natural cherry flavor, methyl para-hydroxybenzoate, caramel, purified water.
SIDE EFFECTS
Skin, subcutaneous tissue disorders: skin rash, urticaria, erythema, exanthema, bullous rash / erythema, pruritus, angioedema, dermatitis. Gastrointestinal disorders: abdominal pain, nausea, vomiting, diarrhea. Nervous system disorders: dizziness. Respiratory, thoracic and mediastinal disorders: dyspnoea. Vascular disorders: redness. Bronchial obstruction with unknown frequency can also occur with mucolytics for oral and rectal use.
PREGNANCY AND BREASTFEEDING
Although the active ingredient is neither teratogenic nor mutagenic and has not shown negative effects on reproductive function in animals, the drug should not be administered during pregnancy. Since no data are available on the passage of carbocysteine lysine salt monohydrate into breast milk, use during lactation is contraindicated.
INDICATIONS
Mucolytic, fluidifying in acute and chronic respiratory diseases.
INTERACTIONS
In controlled clinical studies, no interactions have been shown with the most common drugs used in the treatment of upper and lower respiratory tract diseases, nor with food and with laboratory tests.
DOSAGE
A graduated measuring cup is attached to the package. To open the package it is necessary to press the cap firmly and turn it counterclockwise at the same time. Adults: 15 ml 2-3 times a day or according to medical prescription. Children over 5 years: 5 ml 2-3 times a day or according to medical prescription. Children from 2 to 5 years: 2.5 ml 2-3 times a day or according to medical prescription. In consideration of the pharmacokinetic characteristics, the recommended posology can be maintained even in patients with renal and hepatic insufficiency. Duration of treatment: carbocysteine lysine salt monohydrate can also be used for prolonged periods.
ACTIVE PRINCIPLES
Carbocysteine lysine salt monohydrate equal to 9 g of carbocysteine lysine salt.